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Abstract 
Background 
Awake fibreoptic intubation (FOI) remains the gold standard management of the anticipated difficult airway. An 
organised approach will ensure success and patient comfort. Training has to be rigorous to instil confidence. 
Exposure, practice and level of confidence of awake FOI in the Department of Anaesthesiology at the 
University of the Witwatersrand (Wits), is not known. 
Methods 
Anaesthetists were surveyed with an anonymous self-administered questionnaire. A total of 130 questionnaires 
were distributed at departmental academic meetings over five months and 126 (96.9%) questionnaires were 
returned. 
Results 
The majority (41.2%) had only performed one to five awake FOIs, 12.7% had performed 21 to 50, but 13.5% 
had never performed any. The majority were trained on asleep (39.8%) and awake (31.9%) patients. Only 20.4% 
had manikin, and 4.2% simulator training.  While 58.7% had reasonable levels of confidence, 41.3% had low 
confidence. Midazolam (35.0%) and fentanyl (26.7%) were the most commonly used drugs for sedation 
followed by remifentanil (16.1%) and dexmedetomidine (12.2%). All topicalised the airway prior to awake FOI. 
Lignocaine 2% was the drug of choice (72.2%). Techniques included application of soaked swabs (23.4%), 
spray (22.8%), spray-as-you-go (18.7%), nebulisation (16.4%), gel or ointment (8.8%), transtracheal block 
(6.4%) and gargle (2.9%). 
Conclusion 
Anaesthetists in the Wits Department may not be adequately exposed to awake FOI and demonstrated a marked 
variability in sedation and topicalisation practices. 
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Section 1: Literature review 
1.1 Introduction 
One of the most important tasks of the anaesthetist is airway management. It is critical that the anaesthetist is 
familiar with the mechanisms responsible for predicting a difficult intubation and knows how to handle these 
challenges (1). 
Airway complications are the most common anaesthetic cause of morbidity and mortality. An estimated one 
third of anaesthetic deaths occur as a result of failure to establish an airway and failure to ventilate (2). 
According to the American Society of Closed Claim Analysis, respiratory complications were responsible for 
37% of anaesthetic adverse events. Of these, 72% of the incidents were considered preventable. Difficult 
tracheal intubation rated amongst the most common causes of brain damage and death (3).  
The American Society of Anesthesiology (ASA) guidelines for management of the difficult airway, strongly 
recommends that the “strategy for intubation of the difficult airway should include the identification of a 
primary or preferred approach to awake intubation”. In a survey amongst ASA members, 69% of the consultants 
strongly agreed that the fibreoptic bronchoscope (FB) should be available even for emergency airway 
management (4).  
Awake fibreoptic intubation (FOI) remains the gold standard for the management of the anticipated difficult 
airway in a spontaneously breathing patient (5, 6). By extrapolating the findings of Lee et al. (7) who stated that 
the Trachway ® is preferred to the FB when managing the difficult airway, Ahmad et al. (8) proposed that 
asleep videolaryngoscopy should be the new gold standard. Heidegger (9) and Schechtman et al. (10) however 
emphasized the contrary and encouraged anaesthetists to undergo training and master the technique of FOI (11). 
Wiles (12) concluded that clinical cases requiring FOI will always remain and anaesthetists should be careful 
not to neglect this skill. Awake FOI may be the only possible way of securing a definitive airway in certain 
clinical scenarios for example in a patient who has severe trismus (13). In the fourth National Audit Project 
(NAP4), the Royal College of Anaesthetists emphasised that awake FOI was underutilised when managing a 
difficult airway (14). Failing to use FOI when indicated could result in airway complications and jeopardise 
patient safety (15). In view of its importance, training in FOI is given at the annual ASA conference (16). 
The FB is of further value to the anaesthetist when extubation has to be carefully timed as would be the case in 
vocal cord dysfunction or swelling of the airway (17). In addition, using the FB is superior to clamping and 
auscultation to confirm optimal placement of a double-lumen tube (18). The FB is a helpful tool in the intensive 
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care unit where it can be utilised by the trained anaesthetist to perform diagnostic bronchoscopies as well as 
clear secretions from the airway (19). 
1.2 History  
Awake FOI was founded by Dr Peter Murphy in 1965 when he became the first to intubate a patient’s trachea 
aided by the choledochoscope. Dr Murphy was a senior registrar in anaesthesia at the National Hospital for 
Nervous Disease in London at the time. He obtained a flexible choledochoscope from the American Cystoscope 
Makers Inc. and used it to obtain the first fibreoptic images of the airways during endotracheal intubation (19). 
In the Classic Papers series published in 2010 in the journal Anaesthesia, Calder (19) explained how Dr 
Murphy’s newly described technique resonated with the otolaryngologists long before the anaesthesia 
community realised its value. In 1972 Dr Murphy convinced his department to buy a flexible fibreoptic 
laryngoscope. He described his initial attempts to intubate with this apparatus as “embarrassing”, especially 
because he was considered the forerunner in the field. He proceeded by attempting intubation in the post-
anaesthesia unit where patients’ muscle relaxants had worn off. As Dr Murphy’s skills improve he became 
highly sought after by the head and neck surgeons. 
The first FB was designed in the 1960’s by Shigeto Ikeda from Japan, and advanced by Chevalier Jackson who 
added a suction channel (20). The evolution of the flexible FB has resulted in the development of the video 
bronchoscope (5). The video bronchoscope is regarded as easier to use as it provides a much wider, magnified 
view and therefore the anatomy is easier to recognise. It also allows multiple observers and is therefore a good 
teaching tool (21). 
1.3 Indications and contraindications 
Awake FOI is the standard approach in the clinical scenario where endotracheal intubation is indicated, but 
mask- and supraglottic ventilation is not likely to be successful.  An awake FOI protects against the danger of 
the “cannot intubate cannot ventilate” situation following the induction of a general anaesthetic. Awake FOI 
should be considered in cases of trauma to the face and neck, head and neck tumours, obstructive sleep apnoea, 
obesity, abnormal airway anatomy and previous difficult intubation (5). Awake FOI supersedes other intubation 
techniques like video laryngoscopy in patients with severely limited mouth opening (22). Awake FOI is also the 
preferred technique in cervical spine injury or instability (5, 23). Manipulation of the airway is thereby 
minimised and should prevent neurological injury. The patient can be examined following awake FOI to detect 
any new onset neurological deficit or deterioration in neurological function (5).  
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Absolute contraindications relate mostly to patient non-compliance as well as the patient refusing awake FOI 
despite comprehensive counselling. An inexperienced anaesthetist, patient allergy to local anaesthetic agents, 
bleeding or contamination of the airway and stridor due to tumours of the upper airway, are relative 
contraindications (22, 24). Safety in a patient with an increased aspiration risk is debatable (22), but awake FOI 
may reduce this risk by maintaining protective reflexes (5). Awake FOI should however be avoided in a patient 
who is vomiting (25). 
1.4 The flexible bronchoscope 
The FB is a delicate instrument that has to be meticulously maintained, cleaned and handled with care (26). The 
components of the FB are illustrated by Figure 1. It consists of a body and an insertion cord (5). The body 
contains the eyepiece (1), focusing ring (2), angulation control lever (3), light source adapter (4) and instrument 
channel (5). The insertion cord (6) comprises a column of multiple thin, flexible glass fibreoptic bundles. By the 
principle of total internal reflection the fibres allow an image to be transmitted from its distal end, along the 
length of the fibrescope, to the eyepiece located proximally. The fibres are insulated by thin layers of glass with 
different optical densities. Light is reflected internally along the length of the fibres. Lenses at the tip of the 
scope and the eyepiece allow focus of the image (2, 5).  
 
Figure1: The flexible bronchoscope (5)  
1.5 Preparation 
Awake FOI has to be carefully planned in order to optimise patient comfort, intubation conditions and 
haemodynamic status (27). Standard emergency airway equipment and drugs should be available (5). All 
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anaesthetic and resuscitation equipment should be checked according to a standardised protocol (28). 
Intravenous access must be obtained prior to the procedure (2). 
1.5.1 Psychological preparation 
It is important to thoroughly explain every step of the procedure prior to initiation and to continuously engage 
with the patient during the intubation (24). The patient should understand why this particular technique has been 
chosen (28) and be reassured that comfort and safety will be optimised (5). It is advisable to give the patient 
specific instructions for example to rather raise his or her hand if the anaesthetist should pause and not to speak 
during the procedure. A well-informed patient is likely to be cooperative, allowing the intubation to proceed 
more smoothly (28). 
1.5.2 Positioning 
The patient should be in the seated or supine position and continuous monitoring should be in place (5). In their 
case report, Dabbagh et al. (29) described a dyspnoeic, agitated patient with a rapidly enlarging neck mass who 
could not tolerate the supine position.  The authors suggested that the anaesthetist should practice performing 
awake FOI in patients in the sitting position as well (29). 
Awake FOI may also be performed in the lateral position if necessary to maintain the patency of the airway as 
described by Neumann et al. (30). 
1.5.3 Premedication 
It is advisable to administer an antisialogogue to reduce airway secretions. By maintaining a dry airway, the 
anaesthetist’s view remains unobscured and the topical application of local anaesthetic is more efficacious (28). 
Glycopyrrolate is the drug of choice as it does not cause sedation and has a rapid onset of action (5). Collins et 
al. (5) recommended 0.1 to 0.2 mg glycopyrrolate intravenously while Slavkovic (25) used 0.2 to 0.4 mg. 
Alternatives include atropine, scopolamine (5) and hyoscine (22). Administration of intravenous glycopyrrolate 
should be 20 minutes prior to the intubation (16). The resultant tachycardia caused by its antimuscarinic action 
could be troublesome especially in very anxious patients. This adverse effect could be reduced by intramuscular 
administration of the antisialogogue one hour before the procedure at a dose of 4 µg.kg
-1
 (22). 
If indicated, metoclopramide and ranitidine should be administered at least one hour before the procedure to 
reduce the volume and increase the pH of the gastric contents (31-33). 
In patients who are extremely anxious, an oral anxiolytic may be of value (28). 
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1.5.4 Sedation 
Ideally, a patient undergoing awake FOI should be cooperative, comfortable, well analgised, maintain their own 
ventilation and have no airway secretions. The drug chosen for sedation should therefore be easily titratable, 
short acting and should cause little suppression of respiration (34). As the safety of awake FOI relies on the 
patient breathing spontaneously, it is advisable that a second anaesthetist is present to administer sedation. Over 
sedation may cause apnoea and hypoxia while under sedation may result in the patient being uncooperative (22). 
The question may arise as to whether sedation should be given at all in view of the risk of compromising the 
airway and the resultant hypoxaemia (5). Ho et al. (35) and McGuire et al. (36) have reported cases of complete 
obstruction of the airway while attempting awake FOI in the absence of sedation. Also, awake FOI may cause 
significant discomfort in 20% of patients even with appropriate premedication and titrated sedation (37). A 
variety of drug combinations to facilitate awake FOI have been described over the past 30 years including 
propofol, benzodiazepines, opioids, ketamine and α-2-adrenoreceptor agonists. The practitioner has to select the 
ideal drug based on the particular patient and indication for awake FOI (38). Unfortunately, appropriately-
designed randomised control trials demonstrating superiority of certain drug combinations, are lacking (22).  
Intravenous midazolam administered in small boluses is a popular choice because of its ability to provide 
sedation and anterograde amnesia. A short acting opioid such as fentanyl should be administered simultaneously 
to suppress coughing, depress laryngeal reflexes and offer analgesia (28). This regimen is simple and has been 
widely used. The total dose of midazolam should not exceed 0.05 mg.kg
-1
 and that of fentanyl, 1.5 µg.kg
-1 
(22).  
Achieving the desired level of sedation with propofol alone is extremely difficult (22). If propofol is selected for 
sedation during awake FOI it should be administered as a target controlled infusion (TCI) together with 
remifentanil (38). 
Remifentanil and dexmedetomidine are attractive choices because of their unique characteristics (38). 
Remifentanil is an ultra-short acting opioid with a constant half-life (38) resulting in quick termination of its 
action (22). It suppresses the cough reflex and blunts the cardiovascular responses brought on by airway 
manipulation (38). Remifentanil has been effective as a single agent for sedation in awake FOI but because of 
the high occurrence of memory recall, additional agents may need to be administered (22). Adverse effects of 
remifentanil include hypotension, rigidity of the chest wall (22), respiratory depression and bradycardia (38). 
Remifentanil can however be reversed by an antagonist (38), naloxone, even though higher than usual doses 
may be required when compared to reversal of other opioids (39). 
6 
 
Dexmedetomidine is a selective α-2-adrenergic agonist that acts on the central nervous system (38) to cause 
sedation, analgesia and anxiolysis (22). Dexmedetomidine has a linear pharmacokinetic profile (40) and a 
loading dose of  0.7 to 1 µg.kg-1 over 10 to 20 minutes should be administered for awake FOI (38). Clinical 
advantages in awake FOI are similar to that of remifentanil but in addition, dexmedetomidine provides desirable 
amnesia and does not cause respiratory depression (22).  
A summary of selected literature pertaining sedation for awake FOI is provided in Table 1. 
Table 1: Sedation for awake FOI 
Author Method Conclusion 
Puchner et al. (41) Evaluated remifentanil as a single 
drug for awake FOI as compared to 
fentanyl plus midazolam. 
High doses of incremental 
remifentanil (0.1 to 0.5 µg.kg
-1
. 
min
-1
) improved the intubating 
conditions but patients were more 
likely to recall details of the 
procedure. 
Machata et al. (27) Compared two different continuous 
infusion dosage regimens of 
remifentanil for awake FOI. 
Recommended a remifentanil bolus 
of 0.75 µg.kg
-1
 over 30 seconds at 
the onset followed by 0.075 µg.kg
-
1
.min
-1
. Doubling the doses did not 
show additional benefit and was 
associated with dose dependent 
respiratory suppression and 
increased levels of partial pressure 
of carbon dioxide. The authors 
recommend intravenous 
midazolam 0.05 mg.kg
-1
 as a 
premedication. 
Lallo et al. (42) Compared the efficacy and 
titratability of remifentanil versus 
propofol when administered as a 
TCI during awake FOI. 
Propofol and remifentanil can be 
rapidly titrated according to patient 
response but propofol caused 
significantly more sedation. 
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Author Method Conclusion 
Patients receiving remifentanil 
were more cooperative. 
Remifentanil was a superior choice 
especially when continuous 
spontaneous ventilation was 
essential. 
Bergese et al. (43) Assessed whether 
dexmedetomidine was safe and 
effective when applied as the main 
sedative for a patient undergoing 
awake FOI. 
Dexmedetomidine was a suitable 
alternative agent to sedate patients 
undergoing awake FOI. When 
dexmedetomidine was given, less 
rescue midazolam was required as 
compared to placebo. 
Dexmedetomidine lowered the 
heart rate and blood pressure and 
was associated with greater 
intubation success rate in 
Mallampati class IV airways when 
compared to placebo. 
Bergese et al. (44) Compared dexmedetomidine plus 
midazolam versus midazolam as a 
single sedative for awake FOI. 
Dexmedetomidine rendered 
patients significantly more 
cooperative and calm as compared 
to midazolam. An infusion of 
dexmedetomidine following 
premedication with midazolam was 
more effective than using repeated 
doses of midazolam only for 
conscious sedation during awake 
FOI. 
Ryu et al. (45) Compared outcomes of patients Propofol-dexmedetomidine 
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Author Method Conclusion 
undergoing FB when sedated with 
propofol-remifentanil versus 
propofol-dexmedetomidine. 
administration resulted in fewer 
episodes of desaturation and fewer 
airway secretions but patients 
required more topical anaesthesia 
and took longer to recover. In 
addition, bronchoscopist 
satisfaction was lower with this 
combination. 
Cattano et al. (34) Compared remifentanil versus 
dexmedetomidine as anaesthetic 
agents for awake FOI. 
Remifentanil use resulted in a 
higher success rate with the initial 
attempt. Patients receiving 
dexmedetomidine were much 
slower to attain adequate levels of 
sedation but memory recall was 
lower in this group. 
Dexmedetomidine could be 
valuable in awake FOI but “mid-
level providers” of anaesthesia will 
find remifentanil more beneficial. 
Dhasmana S. (46) IVI Dexmedetomidine 1.0 µg.kg
-1
 
was compared with 1.5 µg.kg
-1
 for 
awake FOI. 
Haemodynamic parameters were 
not significantly different between 
the groups but patient cooperation 
and satisfaction were superior with 
1.5 µg.kg
-1
. 
Eftekharian et al. (47) Compared remifentanil, ketamine 
and propofol for sedation during 
awake FOI. 
Remifentanil was superior to the 
other two drugs with regards to 
time taken to intubate, intubating 
conditions and patient satisfaction. 
Ovassapian A. (48) Recommended titrated boluses of This technique is taught in the Wits 
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Author Method Conclusion 
fentanyl (average dose of 1.5 
µg.kg
-1
 to suppress airway reflexes) 
and midazolam (average dose of 30 
µg.kg
-1
 to prevent memory recall). 
Department of Anaesthesiology 
and is referred to as the Ovassapian 
technique. 
 
1.5.5 Airway anaesthesia 
The airway has to be sufficiently anaesthetised prior to an awake FIO to ensure patient cooperation and comfort 
(23). It improves patient tolerance and acceptability and limits the use of sedation especially when 
haemodynamic stability is essential (49). The combination of local anaesthetics and systemic narcotics 
decreases the risk of toxicity of a drug and limits the discomfort of the intense airway stimulation brought on by 
awake FOI (50). Lignocaine is most commonly used as other local anaesthetic agents such as benzocaine and 
tetracaine have a narrow therapeutic window and are associated with methaemoglobinaemia (5, 6).  
Various techniques should be combined to achieve adequate anaesthesia of the airway (51). For a nasal 
intubation, the mucosa of the nose has to be anaesthetised targeting the V1 and V2 trigeminal nerve branches. 
This can be achieved by directly applying swabs to the mucosa that has been soaked in lignocaine. Ideally a 
0.25% phenylephrine solution should be applied simultaneously to constrict the blood vessels of the mucosa and 
thereby prevent epistaxis (5). Cocaine used to be applied for this purpose (6) but it is a controlled drug and has 
now largely been replaced by a combination of lignocaine and phenylephrine, due to its significant adverse 
effects (52). The toxic dose of cocaine is variable but mostly reported as 3 mg.kg
-1
 in adults (53). Cara et al. (54) 
compared pain scores reported by patients undergoing placement of a nasal tube following topical application of 
cocaine 5% or a combination of phenylephrine 0.5% and lignocaine 5% but found no significant differences. 
They concluded that even though phenylephrine could result in hypertension and bradycardia, it is still 
favourable compared to cocaine which not only causes ischaemia of the myocardium, but also poses a barrier 
with regards to ordering, storing and dispensing of the drug (54). Ovassapian (55) recommended a lignocaine 
4% solution as this delivered satisfactory local anaesthesia with a low risk of toxicity provided that a total dose 
of 3 to 4 mg.kg
-1
 is not exceeded . Alternatively lignocaine can be applied as a gel (2%) or ointment (5%) to the 
nasal mucosa (5). A lignocaine 10% solution should not be applied undiluted as this will result in a stinging 
sensation of the mucosa (56). The onset of action of lignocaine when applied in this fashion is up to five minutes 
(57) so adequate time should be allowed prior to manipulation of the airway (6). 
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To anaesthetise the tongue, oropharynx and larynx, lignocaine can be gargled, nebulised or aerosolised. These 
techniques target the V3 branch of the trigeminal nerve as well as the glossopharyngeal- and vagus nerves (5). 
Lignocaine can also be sprayed onto the base of the tongue and the pharynx keeping in mind that each spray 
dispenses 10 mg of the drug (32). 
The larynx is further anesthetised by using the spray-as-you-go method (6). By utilising the instrument channel 
of the FB (5), a dose of local anaesthetic is sprayed directly onto the vocal cords when visualised (6, 32) 
followed by a second dose sprayed onto the tracheal mucosa as soon as the FB passes through the vocal cords 
(6).  
Regional airway blocks can be used as an alternative to topicalisation, or to enhance its effect, but depends on 
physician experience and patient acceptability. The rapid onset and longer duration of action are definite 
advantages of airway blocks (5). A transtracheal block is performed by inserting a 22-gauge needle through the 
cricothyroid membrane into the tracheal lumen, aspirating air to confirm positioning and then injecting 
lignocaine into the trachea (51) in a caudad direction (33). A vigorous cough reflex will be provoked and the 
local anaesthetic is then sprayed over the area (33), thereby blocking the recurrent laryngeal nerve (51). The 
superior laryngeal nerve can be blocked by holding a cotton swab soaked in lignocaine with a Kraus forceps 
against the mucosa of the piriform fossa for approximately one minute (51, 58).  
Complications of airway blocks include intra-arterial injection, bleeding and injury to local structures (5). In 
view of the potential trauma to the carotid arteries as well as prolonged suppression of airway reflexes, blocking 
the glossopharyngeal nerve by needle infiltration of the tonsillar pillars is discouraged (32). This involves 
infiltration of lignocaine at the level of the thyrohyoid membrane, just inferior to the cornu of the hyoid bone 
(59). Table x provides an overview of the airway nerve supply, anatomy and the techniques which may be 
applied to anaesthetise the airway for awake FOI. 
Table 2: Airway nerve supply and anaesthetic techniques 
Nerve Supply Technique 
Trigeminal Tongue, oropharynx, larynx Topicalise 
Glossopharyngeal Tongue, vallecula, epiglottis, 
tonsils, pharynx 
Topicalise, direct infiltration 
Vagus - superior laryngeal  Tongue, epiglottis, arytenoids Direct infiltration at greater cornu 
of hyoid 
Vagus - recurrent laryngeal  Trachea, vocal cords Topicalise, transtracheal block 
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Excessive doses of local anaesthetic should be avoided as this could result in systemic toxicity. A lignocaine 
plasma concentration of 5 mg.l
-1
 is considered toxic (49). The risk of toxicity is low if a total maximum dose of 
3 to 4 mg.kg
-1
 of lignocaine is administered (6). The overall lignocaine dose should not exceed 7 mg.kg
-1
 (60). It 
is of note that nebulised lignocaine is more likely to be absorbed from the small bronchi thus increasing the 
plasma level (6). 
A summary of selected literature pertaining airway anaesthesia for awake FOI is given Table 3. 
Table 3: Airway anaesthesia for awake FOI 
Author Method Conclusion 
Kundra et al. (37) Described the level of patient 
comfort and haemodynamic 
stability following airway 
nebulisation versus combined 
regional airway blocks. 
Both techniques provided 
satisfactory upper airway 
anaesthesia. Based on a grimace 
score, airway reactivity score and 
haemodynamic parameters, 
patients receiving airway blocks 
were more stable and comfortable. 
Larijani et al. (61)  Evaluated how safe and efficient 
EMLA cream is for anaesthetising 
the airway for awake FOI. 
(EMLA® cream is a eutectic 
mixture of local anaesthetics 
prilocaine 2.5% and lignocaine 
2.5%) 
EMLA® cream was a safe and 
effective alternative to anaesthetise 
the mouth and oropharynx for 
awake oral FOI. Plasma levels of 
the drugs did not reach toxic levels 
and methaemoglobin levels did not 
exceed normal parameters. The 
cream appeared to be palatable and 
in none of the 20 subjects the 
rescue topicalisation protocol had 
to be applied. 
Williams et al. (49) Used nebulised lignocaine to make 
the subsequent topical application 
of local anaesthetic by the spray-
as-you-go method more tolerable. 
All of the 25 non-sedated 
volunteers undergoing awake FOI 
reported the experience as 
acceptable. 
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Author Method Conclusion 
Ji et al. (50) Investigated the efficacy of 
endotracheal administration of 
sufentanil and tetracaine through 
the cricothyroid membrane for 
awake FOI in order to reduce the 
risk of adverse effects of local 
anaesthetic drugs. 
The authors concluded that this 
was a safe and effective alternative 
regimen. 
Gupta et al. (23) Compared ultrasonic nebulisation 
with 10 ml 4% lignocaine to the 
administration of bilateral superior 
laryngeal nerve blocks and 
transtracheal administration of 
lignocaine in combination with 
gargling with lignocaine. 
In a study of 50 patients with 
cervical spine injury undergoing 
awake FOI the quality of airway 
anaesthesia was superior with 
airway blocks as opposed to 
nebulization with lignocaine. 
Patient comfort levels were higher 
and intubation was generally easier 
following the airway blocks. 
Ovassapian A. (48) Recommended lignocaine 4% 
applied to nasal mucosa with 
soaked swabs as well as gargling 
with lignocaine and the 
administration of a transtracheal 
block. 
This technique is taught in the Wits 
Department of Anaesthesiology 
and is referred to as the Ovassapian 
technique. 
 
1.6 Technique 
FOI entails passing an endotracheal tube between the vocal cords by railroading the tube over a flexible 
bronchoscope that continuously provides an image of the airway (28). Successfully executing an awake FOI 
strongly depends on the appropriate preparation of the equipment and the patient (6, 28). The patient has to 
remain as comfortable and haemodynamically stable as possible (27). Particular consideration should be given 
to the pre-operative assessment, explaining to the patient what lies ahead, preparation of the equipment, sedation 
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as well as application of a local anaesthetic to the airways, as previously described (28). The patient should be 
provided with supplemental oxygen (6).  
The anaesthetist should be standing on a stool to prevent the FB from kinking (6) and to allow the anaesthetist to 
hold the insertion cord at the tip for accurate manipulation (28). The anaesthetist may choose to stand at the 
head of the patient as for conventional laryngoscopy as this will preserve the orientation with regards to the 
airway anatomy. When performing an orotracheal FOI the anaesthetist might feel more comfortable standing 
beside the patient, facing the head, which results in an inverted view of the airway. This may be confusing 
especially for the beginner (6). Facing the patient however allows the anaesthetist to observe the monitors as 
well as have eye contact with the patient (62). 
Ensure that the endotracheal tube (ETT) slides easily across the shaft of the FB (6). This can be made easier by 
applying saline or distilled water to facilitate the withdrawal of the FB from the ETT (63). A reinforced ETT is 
preferred as it is more flexible and passes through the nose more easily (6). According to Brull et al. (64), the 
use of a flexible silicone tube resulted in less laryngeal trauma when compared to a polyvinyl tube as it 
advanced more easily over the FB. Completely deflate the cuff of the ETT and liberally apply a lubricant over it 
(6). Avoid lubricating the distal 20 cm of the insertion cord to allow better grip when moving this part by hand 
(28). The insertion cord must be held with only two fingers to prevent unequal pressure points and breakage of 
the fibres (32). 
Both oral and nasal approaches can be followed. Nasal intubation is considered superior because the vocal cords 
are more easily visualised since the FB is less obstructed by the tongue. The nasal approach avoids difficulties 
associated with limited mouth opening and allows for an unobstructed surgical field during maxillofacial and 
ear-, nose- and throat procedures (5). A nasal intubation is more tolerable for the patient and allows for the tip of 
the FB to be guided by the anatomy of the nasopharynx towards the glottis (2). The wider nostril should be used 
for instrumentation. The ETT can be used as a guide for the FB or the ETT can be mounted onto the scope and 
advanced through the nose once the trachea has been identified with the scope. Care should be taken to prevent 
the FB from slipping through the Murphy eye (6). 
In the case of an oral FOI, an intubating airway may be required to facilitate intubation. Bite blocks protect the 
FB from the teeth. Intubating airways and a laryngoscope blade can be used to displace the tongue and maintain 
the scope in the midline (5). Currently available intubating airways include the Ovassapian fibreoptic intubating 
airway, Williams airway intubator and the Berman intubating airway (65). When using the oral approach, the tip 
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of the scope should be tilted 45 degrees towards the oropharynx prior to introducing the scope into the patient’s 
mouth (5). 
A standard FB is ergonomically designed to be held by the right hand while the left hand controls the distal end. 
Avoid bending the insertion cord (25). Insert the FB with the tip directed towards the glottis. Use the 
angulations control lever, operated by the thumb, to steer the tip of the scope towards the vocal cords (5). 
Identify familiar anatomical structures by carefully advancing the FB under visual control. Slowly withdraw the 
FB if the view or orientation is lost (6). 
The first landmark is the epiglottis which should become visible once the turbinate is passed. Next, identify the 
laryngeal opening located underneath the epiglottis. Warn the patient about the airway irritation that will follow 
and then spray the vocal cords with lignocaine once they become visible. Allow 2 to 3 minutes for it to take 
effect in order to avoid coughing and laryngospasm. The FB is then advanced further past the vocal cords into 
the trachea as evidenced by the view of the tracheal cartilage rings. The carina is usually visible at this point. A 
second dose of lignocaine should be sprayed onto the tracheal mucosa. After waiting another two to three 
minutes, railroad the ETT into the trachea while continuously visualising the tracheal rings to prevent the tube 
from accidentally dislodging into the oesophagus or oropharynx (6). The optimal position for the ETT in an 
adult is two to three centimetres above the carina (5). 
As the diameter of the FB is smaller than that of the ETT, the bevel of the ETT may get wedged onto arytenoid 
cartilage (6). If resistance is encountered distal to the pharynx it is mostly either at the epiglottis or the right 
sided arytenoid (66). If this occurs, slightly withdraw the ETT, rotate it counter-clockwise for 45 to 90 degrees 
and gently re-advance (6, 66). Improving the size matching between the ETT and the FB will reduce the risk of 
entrapment of the leading edge of the ETT in the glottic structures. FOI may further be facilitated by performing 
a jaw thrust or by instructing the patient to protrude the tongue (5). 
Once the FB has been withdrawn from the ETT, verify its placement and secure. General anaesthesia should 
then be induced with a rapidly acting intravenous agent (6). 
1.7 Advantages 
FOI is a safe and effective technique. The airway can be evaluated prior to placement of the ETT. FOI can be 
performed on a patient in any position. It is associated with fewer cardiovascular responses than conventional 
laryngoscopy (6). 
  
15 
 
1.8 Limitations and complications 
Even though prices have dropped, the major disadvantage of the FB remains the high cost. Extra time is needed 
to prepare for an awake FOI (67). It is a time consuming procedure and requires a high level of skill (6). 
Complications include local anaesthetic toxicity, laryngospasm, endobronchial intubation, trauma to local 
structures resulting in epistaxis and dislocation of an arytenoid leading to a sore throat, change in voice, 
odynophagia, stridor and dyspnoea (6). FOI may also bring about hypoxaemia and aspiration (5). Perforation of 
the oesophagus and barotrauma are rare but serious complications (68). 
1.9 Current practice guidelines 
The ASA guidelines list awake intubation as a planned, non-invasive strategy to manage the difficult airway (4). 
These guidelines do not include a stepwise approach to awake FOI as such but the ASA published “tips from the 
ASA workshop” that provided details on each step of awake FOI (16). Heidegger (69) commented that the 
updated Difficult Airway Society guidelines (70) should include guidelines for the anticipated difficult airway to 
become “truly revolutionary”. 
The South African Society of Anaesthesiologists adopted the ASA difficult airway algorithm but also does not 
include a specific approach to awake FOI (71). 
Lema et al. (32) developed a step by step method that is applied in the anaesthesia department of the Valle 
University Hospital in Columbia based on the literature, group discussions and personal experience. 
1.10 Teaching and training 
The process of awake FOI is not clearly defined in most scenarios. Personal preference mainly dictates the 
methods applied when performing this procedure (72). FOI should however be conducted in an organised, 
standardised fashion (73) as the quality of the process of FOI relates to the quality of the overall procedure (72). 
Improper sedation is a recognised factor leading to failure of FOI (14) despite many different drugs and drug 
combinations having been applied over the past 30 years (38). It has been shown that adherence to a 
recommended predetermined algorithm, resulted in an 85% success rate with the first attempt (72). Following a 
guideline or protocol prevents the anaesthetist from improvising and increases the likelihood of success 
irrespective of the operator’s expertise in FOI (32). 
To master FOI, the anaesthetist has to develop and execute an intricate set of psychomotor and judgement skills 
(74). The anaesthetist must be familiar with the FB and be able to skilfully manipulate it during the procedure 
(75). It appears however that FOI skills are not taught on a routine basis (74) and trainees feel inadequately 
taught in this domain (15). According to the NAP4, being inexperienced with awake FOI and unfamiliar with 
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the equipment, resulted in avoidance of its application even when indicated (14). Slavkovic at al. (25) came to 
the same conclusion and stated that anaesthetists were insufficiently trained in FOI. Exclusive “on the job 
experiential learning” could produce anaesthetists that are not proficient in FOI (15). A formal teaching program 
in FOI may be required to promote skills development and ensure proficiency in this technique (76). 
Enhancing the FOI skills of the anaesthetist improves airway management while ensuring patient safety. This 
results in a lower incidence of airway injuries and aspiration, shorter intubation time, a reduced number of 
attempts and fewer surgical airways (74). FOI should not be dreaded (16) but be practiced on a routine basis on 
normal airways rather than only in the emergency situation or on difficult airways (6, 77, 78). 
It is unclear what exactly constitutes proficiency in awake FOI (79). Smith et al. (80) suggested that 45 FOIs 
need to be performed in order for an anaesthetist to gain true expertise. According to Pott et al. (81), 46% of 
program directors in the United States and Canada believed that up to 39 supervised awake FOIs and up to 59 
intubations in total (awake and asleep) with the flexible FB have to be performed to gain competency. 
According to Johnson et al. (82), competency is obtained after a trainee has successfully intubated the airway of 
a patient under general anaesthesia at least 10 times with a single attempt in under two minutes.  
Anaesthetic trainees in the United Kingdom perform on average less than 10 FOIs before becoming consultants 
(75). In their study conducted in New Zealand, Dawson et al. (76) concluded that the majority of anaesthetists 
do perform FOI but the frequency may not be adequate to continuously develop and preserve this skill.  
The “see one, do one” training method has existed in medicine for a long time but the advantages of a graduated 
teaching program are now generally recognised (15). Smith et al. (80) concurred that the skill of FOI is best 
attained by formal training programmes rather than relying on incidental learning. According to Collins et al. 
(5), no superior method of teaching has been agreed upon with regards to FOI. Ovassapian et al. (77) stated that 
various learning methods for FOI should be incorporated into a stepwise program including attempts on a model 
followed by identifying the epiglottis with the FB in recovering patients. Finally the trainee would perform an 
awake FOI on a sedated patient. This program received overwhelmingly positive feedback (77). According to 
Bray et al. (83) the most effective approach was training in the department by experienced teachers. A familiar 
environment and low trainee to trainer ratio were beneficial but it may not be ethically correct to expose the 
patient to a novice (83). 
Didactic teaching cannot replace practical training but provides essential knowledge by means of tutorials and 
lectures (84). The complex motor skills required to perform FOI can be practiced on a bench model before 
applying it to a patient (15). The model may be useful in both introducing the technique to the trainee as well as 
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improving essential fibreoptic handling skills (5). Naik et al. (85) found that anaesthesia residents who had 
trained on a bench model prior to transferring their skills onto patients, performed better as compared to those 
trainees who only received classroom teaching. Examples of bench models include the “hit the hole” device and 
the “Oxford fibreoptic teaching box” (15). 
After conducting a FOI workshop utilising manikins, Dykes et al. (86) found an increased success rate in FOI 
and that this technique could be incorporated in the practice of 35% of the participants that completed the 
course. A computerised manikin had been developed that simulated different difficult airway situations thereby 
allowing a training experience that more closely resembled reality (15).  
Closed circuit television has significantly improved acquiring of the skill of nasotracheal FOI. This useful tool 
allows the teacher and the trainee to simultaneously view the intubation. The instructor can thereby demonstrate 
the technique and provide guidance while the trainee is performing the procedure (15). “Virtual simulation” 
provides the most accurate imitation of a lifelike clinical setting (5). By practising with a simulator first, time to 
intubate with the FB is reduced (87) and psychomotor skills are improved (88).   
It is understandable that the anaesthetist may be reluctant to perform an awake FOI on a patient after training on 
a manikin (15). Ovassapian et al. (77) however emphasise the importance of learning on an awake patient. 
Possible sources of awake subjects include the bronchoscopy clinic and the participants of training courses in 
awake FOI (15). Woodall et al. (89) reported that 200 healthy, “self-selected” anaesthetists voluntarily 
underwent awake FOI without sedation as part of a training course at the Norfolk and Norwich University 
Hospital over a nine year period. Further assessment of this approach is however required in view of the 
associated adverse events (89).  
Practising on a recently demised patient is ethically questionable. Considering the number of alternative 
opportunities for the anaesthetist, this is unnecessary. (15) The anatomy of a cat (90) and a pig (91) is 
considerably analogous to that of a human but practising on anaesthetised animals may not be practical and also 
introduces ethical challenges (15). 
Barriers to gaining this skill of awake FOI include lack of teachers (15), lack of clinical cases (76) and pressure 
in theatre for quick turnover of cases (11, 83). 
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Abstract 
Background 
Awake fibreoptic intubation (FOI) remains the gold standard management of the anticipated difficult airway. An 
organised approach will ensure success and patient comfort. Training has to be rigorous to instil confidence. 
Exposure, practice and level of confidence of awake FOI in the Department of Anaesthesiology at the 
University of the Witwatersrand (Wits), is not known. 
Methods 
Anaesthetists were surveyed with an anonymous self-administered questionnaire. A total of 130 questionnaires 
were distributed at departmental academic meetings over five months and 126 (96.9%) questionnaires were 
returned. 
Results 
The majority (41.2%) had only performed one to five awake FOIs, 12.7% had performed 21 to 50, but 13.5% 
had never performed any. The majority were trained on asleep (39.8%) and awake (31.9%) patients. Only 20.4% 
had manikin, and 4.2% simulator training.  While 58.7% had reasonable levels of confidence, 41.3% had low 
confidence. Midazolam (35.0%) and fentanyl (26.7%) were the most commonly used drugs for sedation 
followed by remifentanil (16.1%) and dexmedetomidine (12.2%). All topicalised the airway prior to awake FOI. 
Lignocaine 2% was the drug of choice (72.2%). Techniques included application of soaked swabs (23.4%), 
spray (22.8%), spray-as-you-go (18.7%), nebulisation (16.4%), gel or ointment (8.8%), transtracheal block 
(6.4%) and gargle (2.9%). 
Conclusion 
Anaesthetists in the Wits Department may not be adequately exposed to awake FOI and demonstrated a marked 
variability in sedation and topicalisation practices. 
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Introduction 
The inappropriate management of a difficult airway is the most common anaesthetic cause of morbidity and 
mortality.
1
 According to the American Society of Closed Claim Analysis, respiratory complications were 
responsible for 37% of anaesthetic adverse events. Of these, 72% were considered preventable. Difficult 
tracheal intubation rated amongst the most common causes of brain damage and death.
2
 It is critical that the 
anaesthetist is familiar with the mechanisms responsible for predicting a difficult intubation and knows how to 
manage these challenges.
3
 Awake FOI remains the gold standard for the management of an anticipated difficult 
airway in a spontaneously breathing patient 
4-6
 despite claims that recent airway advances may supersede the 
fibreoptic bronchoscope (FB).
7, 8
 Failing to use FOI when indicated could result in airway complications and 
jeopardise patient safety.
9
 
To master FOI, the anaesthetist has to develop an intricate set of psychomotor and judgement skills.
10
 The 
anaesthetist must be familiar with the FB and be able to skilfully manipulate it during the endoscopy.
11
 It 
appears however that FOI skills are not taught on a routine basis 
10
 and trainees feel inadequately  taught in this 
domain.
9
 Even though FOI was considered a core skill amongst anaesthetists in a United Kingdom based 
survey, McNarry et al.
11
 found that trainees did not meet the target number of intubations thought to deem them 
competent.  Kristensen et al.
12 
found the majority of anaesthesiologists in a Danish study had no or little 
experience in performing FOI despite having adequate access to the FB.  
Lacking experience and being unfamiliar with awake FOI may result in avoidance of the procedure altogether.
13
 
The Fourth National Audit Project of the Royal College of Anaesthetists indicated that FOI was underutilised in 
managing difficult airways, possibly due to a lack of confidence to perform awake FOI.
14
 Kluger et al.
15 
concurred that anaesthetists were hesitant to perform awake FOI based on the results of the Australian Incident 
Monitoring Study. Factors that may limit the development of this skill include small numbers of clinical cases
16
, 
pressure in theatre for quick turnover
17
, fear of failing and equipment being unavailable.
18
 
Exclusive “on the job experiential learning” could produce anaesthetists that are not proficient in FOI.9 The “see 
one, do one” training method has existed in medicine for a long time but the advantages of a graduated teaching 
program are now generally recognised.
19
 A formal teaching program in FOI may be required to promote skills 
development and learning.
16
  
Successfully executing an awake FOI strongly depends on the appropriate preparation of the equipment and the 
patient.
5, 20
 The patient has to remain as comfortable and haemodynamically stable as possible.
21
 Particular 
consideration should be given to the pre-operative assessment, explaining to the patient what lies ahead, 
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preparation of the equipment, sedation as well as application of a local anaesthetic to the airways.
20
 The process 
of awake FOI is not clearly defined in most scenarios. Personal preference mainly dictates the methods applied 
when performing this procedure 
22 
but awake FOI should be conducted in an organised fashion.
23
 Adherence to a 
recommended predetermined algorithm resulted in an 85% success rate with the first attempt.
22 
Including FOI as 
an essential element in a departmental intubation algorithm resulted in a negligible FOI failure rate.
24
 
Method 
Approval to conduct the study was obtained from the Human Research Ethics Committee (Medical) and the 
Graduate Studies Committee of Wits. A convenience sampling method was used by means of an anonymous 
self-administered questionnaire. A prospective, contextual, descriptive research design was followed. The study 
population consisted of the anaesthetists working in the Wits Department of Anaesthesiology. 
A total of 130 questionnaires were handed out at departmental academic meetings over a period of five months 
and 126 (96.9%) questionnaires were returned. This represents 58% of the anaesthetists in the department. 
Data was entered into a Microsoft Excel® spreadsheet and analysed using frequencies and percentages.  
To determine if there was a significant relationship between level of confidence (very low and low or average, 
high and very high) between junior and senior anaesthetists, we employed a Chi
2
 test for independence. 
Results 
The demographic information of the participants is shown in Table I including gender, age, professional 
designation and years of experience in anaesthesia. 
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Table I: Demographic data 
Demographic  
n = 126  
n (%) 
Gender  
Female 81 (64.2) 
Male 45 (35.8) 
Age  
25-30 Years 25 (19.8) 
31-35 Years 67 (53.2) 
36-40 Years 15 (11.9) 
41-45 Years 9 (7.1) 
46-50 Years 5 (4.0) 
>50 years 5 (4.0) 
Professional designation  
Medical officer 10 (7.9) 
Registrar – 1st, 2nd, 3rd year 43 (34.1) 
Registrar – 4th year 21 (16.7) 
Career medical officer/Consultant 51 (40.5) 
Missing data 1 (0.8) 
Years of experience in anaesthesia  
≤5 Years 55 (43.6) 
>5 Years 67 (53.2) 
Missing data 4 (3.2) 
 
The number of awake FOIs performed by the participants as well as the approximate frequency of performing 
awake FOI is shown in Table II. The 17 (13.4%) participants who had never performed awake FOI were not 
included in the frequency.  These participants were instructed not to fill in the remainder of the questionnaire. 
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Table II: Number of awake FOIs performed and frequency of performing awake FOI 
FOIs 
n = 126 
n (%) 
Number of awake FOIs performed  
Nil 17 (13.5) 
1-5 52 (41.2) 
6-10 20 (15.9) 
11-20 16 (12.7) 
21-50 16 (12.7) 
>50 3 (2.4) 
Missing data 2 (1.6) 
Frequency  
Almost never 3 (2.7) 
Daily 0 (0.0) 
Weekly 3 (2.7) 
Monthly 25 (23.0) 
Annually 49 (45.0) 
Other 27 (24.8) 
Missing data 2 (1.8) 
 
Participants who selected “other” specified that they would perform awake FOI only when a difficult airway 
was anticipated. 
The training methods utilised by anaesthetists to perform awake FOI as well as the combinations of training 
methods selected by participants are shown in Table III. Participants could select more than one option. 
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Table III: Methods for training to perform awake FOI 
Training method n (%) 
Nil 3 (1.4) 
Patient asleep 86 (39.8) 
Patient awake 69 (31.9) 
Manikin  44 (20.4) 
Simulator 9 (4.2) 
Other 5 (2.3) 
Combinations of training methods 
n = 109 
 
Nil 3 (2.8) 
Patient – awake 10 (9.2) 
Patient – asleep  18 (16.5) 
Manikin 3 (2.7) 
Patient - asleep, Patient – awake 27 (24.8) 
Manikin, Patient – asleep 13 (11.9) 
Manikin, Patient – awake  3 (2.8) 
Manikin, Patient - asleep, Patient - 
awake   
20 (18.3) 
Simulator, Patient – awake  1 (0.9) 
Simulator, Patient – asleep  1 (0.9) 
Simulator, Patient - asleep, Patient – 
awake    
2 (1.8) 
Manikin, Simulator, Patient – awake  1 (0.9) 
Manikin, Simulator, Patient - asleep, 
Patient – awake   
3 (2.8) 
Manikin, Simulator, Patient - asleep, 
Patient - awake, Other - Airway 
courses 
1 (0.9) 
  
38 
 
Patient - awake, Other – Observation 
only  
1 (0.9) 
Patient - asleep, Other – Self training, 
Other - YouTube  
1 (0.9) 
Other - Self training  1 (0.9) 
 
Participants who selected “other” specified that they trained by observing awake FOI, attending airway 
workshops and self-training by watching educational material on YouTube® or studying the literature (two 
participants). 
The self-perceived level of confidence of anaesthetists when performing awake FOI is shown in Table IV. 
Table IV: Level of confidence when performing awake FOI 
Level of confidence 
n = 109 
n (%) 
Very low 19 (17.4) 
Low 26 (23.9) 
Average 43 (39.4) 
High 15 (13.8) 
Very high 6 (5.5) 
 
The factors that contributed to the anaesthetist’s proficiency in awake FOI are shown in Table V. The total 
column reflects the number of participants who completed the particular question.  
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Table V: Factors contributing to proficiency in awake FOI 
Factor Strongly disagree 
n (%) 
Disagree 
n (%) 
Agree 
n (%) 
Strongly agree 
n (%) 
Total 
n 
Equipment availability 1 (1) 9 (8.6) 36 (34.3) 59 (56.2) 105 
Equipment functionality 1 (1) 6 (5.8) 42 (40.4) 55 (52.9) 104 
Number of cases available 2 (1.9) 13 (12.6) 50 (48.5) 38 (36.9) 103 
Practicing on normal airways 5 (4.8) 14 (13.5) 47 (45.2) 38 (36.5) 104 
Airway workshops 5 (4.8) 15 (14.4) 63 (60.6) 21 (20.2) 104 
Time available 2 (1.9) 18 (17.1) 60 (57.1) 25 (23.8) 105 
Availability of a FOI algorithm 8 (7.8) 36 (35) 43 (41.7) 16 (15.5) 103 
 
In Table VI the position of the anaesthetist relative to the patient as well as the anaesthetist’s preferred approach 
are shown. One participant specified that positioning would depend on the clinical scenario. 
Table VI: Positioning of the anaesthetist when performing awake FOI and the preferred approach 
Positioning and approach 
n = 109 
n (%) 
Positioning  
Facing the patient 23 (21.1) 
Behind the patient  40 (36.7) 
Elevated 7 (6.4) 
Facing the patient, Elevated,  7 (6.4) 
Behind the patient, Elevated,  18 (16.5) 
Facing the patient, Same level as the patient,  4 (3.7) 
Facing the patient, Behind the patient,  4 (3.7) 
Elevated, Other – Depends 1 (0.9) 
Facing the patient, Behind the patient, Elevated 2 (1.8) 
Behind the patient, Same level as the patient,  1 (0.9) 
Facing the patient, Behind the patient, Same level as the patient 1 (0.9) 
Missing data 1 (0.9) 
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Preferred approach  
Nasal 98 (89.9) 
Oral 6 (5.5) 
Other 2 (1.8) 
Missing data 3 (2.8) 
 
Administration of an antisialogogue as a premedication was indicated by 80 (73.4%) participants. 
Glycopyrrolate was the most commonly administrated premedication by 76 (95.0%) participants, while two 
(2.5%) of the participants selected either glycopyrrolate or atropine. All but one (1.3%) of the participants 
administered glycopyrrolate intravenously and the most commonly administered dose was 0.2 to 0.4 mg by 55 
(79.7%) participants. 
Sedation was administered by 86 (78.8%) participants and three (2.7%) participants indicated that 
administration of sedation would depend on the clinical scenario. The most commonly used technique for 
sedation was titrated boluses by 68 (71.65%) participants followed by administration of an infusion by 16 
(16.8%) participants and target controlled infusion by six (6.3%) participants. The most frequently used drug for 
sedation was midazolam given by 63 (35.0%) participants followed by fentanyl by 48 (26.7%) participants, 
remifentanil by 26 (16.1%) participants and dexmedetomidine by 22 (12.2%) participants. 
All the participants indicated that they topicalised the airway with a local anaesthetic prior to awake FOI. 
Multiple options could be selected with regards to techniques of topicalisation. The most frequently selected 
techniques are shown in Table VII.  
Table VII: Techniques for topicalisation  
Technique n (%) 
Apply soaked swaps 80 (23.4) 
Spray 78 (22.8) 
Spray-as-you-go 64 (18.7) 
Nebulise 56 (16.4) 
Apply gel or ointment 30 (8.8) 
Transtracheal block 22 (6.4) 
Gargle 10 (2.9) 
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A transtracheal block was not listed as an option but participants specified this block in “other”. Lignocaine 2% 
was the preferred local anaesthetic by 104 (72.2%) participants followed by lignocaine 10% selected by 26 
(18.1%) participants. Phenylephrine was applied to the airway by five (3.5%) participants even though this was 
not listed as an option. 
There was a statistically significant difference in the level of confidence of junior and senior anaesthetists with 
senior anaesthetists being more confident than junior anaesthetists [Chi
2
(1) = 40.58, p-value < 0.01%].  
Discussion 
Different authors have conflicting ideas of what exactly constitutes proficiency of awake FOI. According to Pott 
et al.
25
, 46% of program directors in North America believed that up to 39 supervised awake FOIs and up to 59 
intubations in total (awake and asleep) with the FB have to be performed to gain competency. Smith et al.
26
 
suggested that 45 FOIs must be performed in order for an anaesthetist to gain true expertise. Johnson et al.
27
 
stated that competency in FOI was obtained after a trainee has successfully intubated the airway of a patient 
under general anaesthesia with the FB at least 10 times with a single attempt in under two minutes. In our study, 
12.7% of the participants performed between 21 and 50 awake FOIs, thus complying with the literature, while 
41.2% performed one to five awake FOIs and 13.5% had never performed awake FOI in their career. It is 
possible that the majority of the participants in our study had not performed sufficient numbers of awake FOIs 
to become proficient in this skill. Similar results had been found in the United Kingdom where anaesthetic 
trainees performed on average less than 10 FOIs before becoming consultants
11
 as well as New Zealand where 
the majority of anaesthetists did not perform the adequate numbers of FOIs required to continuously develop 
and preserve this skill.
16
 An estimated 25 FOIs had been performed by 34% of North American anaesthesiology 
residents by the time they graduate.
25
 
Awake FOI was performed approximately once a year by 45.0% of participants, while 24.8% performed awake 
FOI only when facing a difficult airway. FOI should be practiced on a routine basis on normal airways rather 
than only in the emergency situation or on difficult airways.
5, 28, 29
 The FB is however a delicate instrument
30
 and 
its maintenance has financial implications resulting in everyday FOIs being discouraged in our setting. 
In our study participants were mostly being trained on either an asleep (39.8%) or awake (31.9%) patient. Even 
though manikins were available in the Wits Department of Anaesthesiology and at the annual airway workshop, 
only 20.4% of participants trained on a manikin. Participants overall had little exposure to training on a 
simulator (4.2%). According to Collins et al.
4
, no superior method of teaching had been agreed upon with 
regards to FOI but Dykes et al.
31
 found that the success rate increased in awake FOI after participants completed 
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a workshop that utilized manikins. In addition, awake FOI could be incorporated in the practice of 35% of the 
participants that completed the course
31
 based on feedback provided by the attendants by means of a 
questionnaire. By practising with a simulator first, time to intubate with the FB was reduced
32
 and psychomotor 
skills were improved.
33
 Ovassapian et al.
28
 advocated stepwise teaching which incorporated various learning 
methods for awake FOI including attempts on a model followed by identifying the epiglottis in recovering 
patients and finally performing an awake FOI in a sedated patient. The participants in our study had not been 
readily exposed to the various FOI training devices.  
While 58.7% of the participants had an average, high or very high level of confidence when performing awake 
FOI, 41.3% of participants had low or very low confidence. According to the Fourth National Audit Project of 
the Royal College of Anaesthetists, a lack of confidence to perform awake FOI may explain why FOI was 
underutilised in managing difficult airways in the United Kingdom.
14
 
Raveendra
10
 stated that the lack of availability of the FB resulted in FOI not being taught routinely in India. In 
our study however, 90.5% of participants agreed or strongly agreed that equipment for awake FOI was readily 
available. Equipment was also functional according to 93.3% of participants. Proficiency in awake FOI was not 
being limited by the number of cases available as indicated by 88 (85.4%) participants. This differs from the 
findings of Dawson et. al
16
 who identified a lack of clinical cases in New Zealand as a barrier to developing this 
skill. Practising on normal airways had been agreed or strongly agreed upon by 81.7% of participants in our 
study as a factor that positively contributed towards their skill in awake FOI. Exposure to airway workshops 
made anaesthetists more proficient in FOI as indicated by 80.8% of participants which concurs with Rosenblatt 
et al.
34
 who stated that anaesthetists who attend airway workshops were more likely to utilise the FB. Time 
constraints did not have a negative impact on their learning of FOI as indicated by 81.0% of participants. Bray et 
al.
17
 and Fitzgerald et al.
18
 identified the pressure in theatre for quick turnover of cases as a factor that may 
prevent adequate opportunity for awake FOI, but in our study participants mostly agreed or strongly agreed this 
was not the case. Even though 42.7% of participants did not agree, 57.3% of participants indicated that the 
availability of an algorithm positively influenced their proficiency in awake FOI. This concurs with the 
recommendation of Heidegger et al.
22
 that adherence to a recommended predetermined algorithm, resulted in an 
85% success rate with the first intubation attempt. 
Participants generally positioned themselves behind the patient. Standing beside the patient, facing the head, 
resulted in an inverted view of the airway which might be confusing especially for the beginner.
5
 The 
overwhelming majority (89.9%) of the participants usually used the nasal approach. Collins et al.
4
 explained that 
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both the oral and nasal approaches could be followed. Nasal intubation was considered superior because the 
vocal cords were more easily visualised due to the FB being less obstructed by the tongue. The nasal approach 
avoided difficulties associated with limited mouth opening and allowed for an unobstructed surgical field during 
maxillofacial and ear-, nose- and throat procedures.
4
 A nasal intubation was more tolerable for the patient and 
allowed for the tip of the FB to be guided by the anatomy of the nasopharynx towards the glottis.
1
 
Glycopyrrolate was administered as an antisialogogue by 95% of participants demonstrating a uniform practice 
with regards to premedication. According to Collins et al.
4
, glycopyrrolate was the drug of choice as it did not 
cause sedation and had a rapid onset of action. The recommended dose by Collins et al.
4
 was 0.1 to 0.2 mg. A 
higher dose was generally given in our study namely 0.2 to 0.4 mg which concurred with the recommendation 
of Slavkovic et al.
19
 
Ideally, a patient undergoing awake FOI should be cooperative, comfortable, well analgised and maintain their 
own ventilation.
35
 Over-sedation may result in apnoea and hypoxia. Inadequate sedation and analgesia may 
render the patient uncooperative.
13
 A variety of drug combinations to facilitate awake FOI had been described 
over the past 30 years, including propofol, benzodiazepines, opioids, ketamine and α-2-adrenoreceptor agonists. 
The practitioner had to select the ideal drug based on the particular patient and indication for awake FOI.
36 
Unfortunately, appropriately designed randomised control trials demonstrating superiority of certain drug 
combinations are lacking.
13
 
Our study showed a noticeable variation in sedation practises. Midazolam (35.0%) and fentanyl (26.7%) were 
the most commonly selected drugs followed by remifentanil (16.1%) and dexmedetomidine (12.2%). The 
combination of midazolam and fentanyl was proposed by the founder of FOI, Ovassapian.
37
 Walsh et al.
20
 
agreed that intravenous midazolam administered in small boluses was a popular choice because of its ability to 
provide sedation and anterograde amnesia. A short acting opioid such as fentanyl should be administered 
simultaneously to suppress coughing, depress laryngeal reflexes and offer analgesia.
20
  
Remifentanil was used by 16.1% of participants. Puchner et al.
38
 evaluated remifentanil as a single drug for 
awake FOI and found that high doses of incremental remifentanil improved the intubating conditions but 
patients were more likely to recall details of the procedure. This concurred with Leslie et al.
13
 who stated that 
remifentanil could be effective as a single agent for sedation in awake FOI but because of the high occurrence of 
memory recall, additional agents may need to be administered. Adverse effects of remifentanil include 
respiratory depression and bradycardia.
36
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Dexmedetomidine was used by 12.2% of participants. According to Leslie et al.
13
 dexmedetomidine caused 
sedation, analgesia and anxiolysis, provided desirable amnesia and did not cause respiratory depression. Bergese 
et al.
39
 found patients to be more calm and cooperative when dexmedetomidine was administered following 
premedication with midazolam as compared to repeated doses of midazolam only for conscious sedation during 
awake FOI. When Cattano et al.
35
 compared remifentanil and dexmedetomidine as anaesthetic agents for awake 
FOI, remifentanil use resulted in a higher success rate with the initial attempt. Patients receiving 
dexmedetomidine were much slower to attain adequate levels of sedation but memory recall was lower in this 
group.
35
 This concurred with the findings of Liu et al.
40
 who stated that time to intubate was lower with 
remifentanil as compared to dexmedetomidine because an adequate level of sedation was achieved significantly 
slower with dexmedetomidine. Dexmedetomidine has a linear pharmacokinetic profile
41
 and a loading dose of 
0.7 to 1 µg.kg
-1
 over 10 to 20 minutes should be administered for awake FOI.
36
 
Local anaesthetics should be applied to the airways to further decrease the discomfort of the intense airway 
stimulation brought on by awake FOI.
42
 All the participants in our study topicalised the airway prior to awake 
FOI. Lignocaine was the drug of choice (72.2%) and the preferred strength was 2%. Lignocaine 4% is not 
available in our setting but could be prepared by dilution of a 10% solution. Collins et al.
4
 and Koerner et al.
5
 
concurred that lignocaine was the most commonly used drug as other local anaesthetic agents such as 
benzocaine and tetracaine have a narrow therapeutic window and are associated with methaemoglobinaemia. 
Ovassapian
43
 however recommended a lignocaine 4% solution as this delivered satisfactory local anaesthesia 
with a low risk of toxicity, provided that a total dose of 3 to 4 mg.kg
-1
 was not exceeded.
43 
Xue et al.
44
 found no 
significant differences in the intubating conditions when lignocaine 2% was compared to 4% but lower plasma 
levels were found with a 2% solution. Lignocaine 10% was selected by 18.1% of participants but according to 
Woodall
45
, a 10% solution should not be applied to the mucosa undiluted as this resulted in a stinging sensation.  
A vasoconstrictor such as phenylephrine was applied to the nasal mucosa by 3.5% of participants. This may not 
accurately reflect the practice of the department as it was not listed as an option in the questionnaire. Collins et 
al.
4
 and Fulling et al.
46
 supported the application of lignocaine 2% plus phenylephrine 0.25% as a 
vasoconstrictor to prevent bleeding. 
The preferred techniques for topicalisation were the application of soaked swabs (23.4%) followed by spray 
(22.8%), spray-as-you-go (18.7%), nebulise (16.4%), application of a gel or ointment (8.8%) and gargle (2.9%). 
A transtracheal block was performed by 6.4% of the participants. This number may not be fully representative 
as the transtracheal block was not listed as an option in the questionnaire but rather specified by participants as 
45 
 
“other”. Collins et al.4 stated that for a nasal intubation, the mucosa of the nose must be anaesthetised by directly 
applying soaked swabs, and the tongue, oropharynx and larynx could be anaesthetised by gargling or nebulising 
with lignocaine. Nebulised lignocaine was more likely to be absorbed from the small bronchi thus increasing 
systemic drug levels.
5
 Lema et al.
47
 recommended spraying of lignocaine onto the base of the tongue and 
pharynx, gargling with lignocaine as well as the spray-as-you-go method which allowed anaesthesia of the vocal 
cords when they appear in the visual field.
47
 Performing nerve blocks depends on physician experience and 
patient acceptability. The rapid onset and longer duration of action are definite advantages of airway blocks.
4
 
According to Leslie et al.
13
, transtracheal lignocaine resulted in excellent anaesthesia of the airway. Koerner et 
al.
5
 preferred the spray-as-you-go technique to airway blocks as it was equally effective in suppressing airway 
reflexes in their experience, yet was less invasive. Lema et al.
47
 discouraged blocking of the glossopharyngeal 
nerve by needle infiltration of the tonsillar pillars in view of the potential trauma to the carotid arteries and 
prolonged suppression of airway reflexes. Kundra et al.
48
 however concluded that patients receiving combined 
regional airway blocks were more stable and comfortable during awake FOI compared to patients who only 
received local anaesthesia by nebulisation. Gupta et al.
49
 concluded that bilateral superior laryngeal nerve blocks 
and a transtracheal block in combination with gargling was superior to nebulization with lignocaine judging by 
patient comfort levels and ease of intubation. Reasoner et al.
50
 showed that the combination of nebulisation and 
a transtracheal block provided airway anaesthesia equal to bilateral glossopharyngeal- and superior laryngeal 
nerve blocks. 
The process of awake FOI is not clearly defined in most scenarios. Personal preference mainly dictated the 
methods applied when performing this procedure.
22
 The traditional approach by Ovassapian
37
 is taught in the 
Wits Department of Anaesthesiology, namely titrated boluses of fentanyl (to suppress airway reflexes) and 
midazolam (to prevent memory recall), application of lignocaine soaked swabs to the nasal mucosa as well as 
gargling with lignocaine and the administration of a transtracheal block. 
Conclusion 
Anaesthetists in the Wits Department of Anaesthesiology may not be adequately exposed to awake FOI and 
demonstrated a marked variability in sedation and topicalisation practices. A standard operating procedure for 
the process of awake FOI could be developed which may ultimately optimise patient care as anaesthetists in this 
study lacked confidence and experience with the procedure. 
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Section 5: Proposal 
5.1 Introduction 
The inappropriate management of a difficult airway is the most common anaesthetic cause of morbidity and 
mortality (1). Awake fibreoptic intubation (FOI) remains the gold standard for the management of an anticipated 
difficult airway in a spontaneously breathing patient (2, 3). FOI entails passing an endotracheal tube between the 
vocal cords by railroading the tube over a flexible bronchoscope that continuously provides an image of the 
airway (4).  
One of the most important tasks of the anaesthetist is airway management. It is critical that the anaesthetist is 
familiar with the mechanisms responsible for predicting a difficult intubation and knows how to manage these 
challenges. (5) The anaesthetist should therefore be exposed to a wide range of techniques and equipment 
utilized in managing the difficult airway including that of FOI. In certain clinical scenarios, FOI may be the only 
possible way of securing a definitive airway. For example, the fibreoptic bronchoscope (FB) may be the only 
instrument suitable for intubating patients with severe trismus (6). 
To master FOI, the anaesthetist has to develop and execute an intricate set of psychomotor and judgement skills 
(7). Sound knowledge of the airway anatomy is required. The anaesthetist must be familiar with the FB and be 
able to skilfully manipulate it during the endoscopy (8). It appears however that FOI skills are not taught on a 
routine basis (7) and trainees feel inadequately taught in this domain (9). Even though FOI was considered a 
core skill amongst anaesthetists in a United Kingdom based survey, McNarry et al. (8) found that trainees did 
not meet the target number of intubations thought to deem them competent. According to Kristensen et al. (10), 
the majority of anaesthesiologists in a Danish study had no or little experience in performing FOI despite having 
adequate access to the FB. 
Small numbers of clinical cases and insufficient practise have been identified as factors limiting the 
development of this skill (11). As a result, anaesthetists do not feel confident to perform FOI. The Fourth 
National Audit Project of the Royal College of Anaesthetists indicated that FOI was underutilised in managing 
difficult airways, possibly due to a lack of confidence to perform the procedure (12). According to Kluger et al. 
(13), the Australian Incident Monitoring Study indicated that anaesthetists were hesitant to perform FOI. Failing 
to use FOI when indicated could result in airway complications and jeopardise patient safety (9). 
Exclusive “on the job experiential learning” could produce anaesthetists that are not proficient in FOI (9). A 
formal teaching program in FOI may be required to promote skills development and learning (11). 
Implementing training measures have resulted in an increase in the average number of FOI’s performed (14). 
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Smith et al. (15) illustrated that an average of 45 FOI’s may need to be performed before a candidate can be 
considered competent. 
Successfully executing an awake FOI strongly depends on the appropriate preparation of the equipment and the 
patient (3, 4). The patient has to remain as comfortable and haemodynamically stable as possible (16). Particular 
consideration should be given to the pre-operative assessment, explaining to the patient what lies ahead, 
preparation of the equipment, sedation as well as application of a local anaesthetic to the airways (4).  
The process of awake FOI is not clearly defined in most scenarios. Personal preference mainly dictates the 
methods applied when performing this procedure. The quality of the process of FOI does however relate to the 
quality of the procedure (14).  For example, over the past 30 years many different drugs and drug combinations 
have been applied (17), each with their own advantages and disadvantages. Competency in FOI is not 
necessarily reflected by the number of intubations performed but also depends on meeting the objectives of the 
intubation (9). FOI should therefore be conducted in an organised, standardised fashion (18). It has been shown 
that adherence to a recommended predetermined algorithm resulted in an 85% success rate with the first attempt 
(14). Including FOI as an essential element in a departmental intubation algorithm has also resulted in a 
negligible FOI failure rate (19).  
5.2 Problem statement 
As airway specialists, anaesthetists are required to skilfully manage the anticipated difficult airway. FOI is an 
indispensable tool for the anaesthetist to handle this clinical scenario (1). If FOI is not applied when indicated or 
is poorly executed, it could lead to devastating complications including cerebral hypoxia and death. 
Anaesthetists should be trained to perform FOI and should regularly perform this procedure to remain confident 
and proficient (20). The literature suggests however that, despite its crucial role, FOI skills are not routinely 
taught during a training program (7), existing training opportunities are not adequate and trainees do not have 
the confidence to perform FOI (12).  
Even though the process of FOI is influenced by personal preference, it is essential to evaluate the process of 
FOI and not only the result (14). In the awake patient that breathes spontaneously, meticulous attention has to be 
paid to sedation and analgesia to achieve a balance between good intubating conditions and patient comfort. 
Over-sedation may result in apnoea and hypoxia. Inadequate sedation and analgesia may render the patient 
uncooperative (21). Both scenarios predispose the patient to morbidity despite being successfully intubated (14).  
A marked difference in practice of FOI between anaesthetists may reflect a lack of structure in this process. An 
organised teaching program in FOI may be beneficial for anaesthesia trainees (21). 
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The exposure, level of confidence and practice of awake FOI in the Department of Anaesthesiology at the 
University of the Witwatersrand (Wits), is not known. 
5.3 Aim 
The aim of the study is to describe the practice of awake FOI in adult patients amongst anaesthetists working in 
the Department of Anaesthesiology at Wits. 
5.4 Objectives 
The primary objectives of the study are to: 
 describe the exposure of anaesthetists to awake FOI 
 describe the self-perceived level of confidence of anaesthetists in performing awake FOI   
 describe the aspects that may contribute to proficiency in awake FOI 
 describe the practice of awake FOI including preparation, sedation and technique. 
The secondary objective of the study is to compare the level of confidence in performing awake FOI between 
junior and senior anaesthetists. 
5.5 Research assumptions 
The following definitions will be used in the study. 
Anaesthetist: any qualified doctor working in the Department of Anaesthesiology including medical officers, 
registrars and consultants. 
Medical officer: a qualified doctor practising in the Department of Anaesthesiology under specialist 
supervision. Medical officers with more than 10 years of experience as an anaesthetist are career medical 
officers and are regarded as consultants.  
Registrar: a qualified doctor who is registered with the Health Professional Council of South Africa as a trainee 
anaesthetist. 
Consultant: a doctor that has successfully completed all the College of Anaesthetists examinations, or 
equivalent, and meet all criteria required to become a specialist. Career medical officer are included in this 
group. 
Junior anaesthetist: a medical officer or registrar with three or less years of training. 
Senior anaesthetist: a fourth year registrar, consultant or career medical officer. 
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5.6 Demarcation of study field 
The study will be conducted in the Department of Anaesthesiology, affiliated to the Faculty of Health Sciences 
at Wits. The department consists of 21 medical officers, 12 career medical officers, 112 registrars and 74 
consultants.  
The following hospitals are affiliated to the department. 
 Charlotte Maxeke Johannesburg Academic Hospital, a central hospital with 1200 beds, 23 theatres and 
do 23 000 theatre cases per annum. 
 Chris Hani Baragwanath Academic Hospital, a central hospital with 2888 beds, 25 theatres and do 
approximately 65 000 theatre cases per annum. 
 Helen Joseph Hospital, a tertiary hospital with 500 beds, 7 theatres and do approximately 6000 theatre 
cases per annum. 
 Rahima Moosa Mother and Child Hospital has 338 beds, 5 theatres and do approximately 6700 theatre 
cases per annum. 
5.7 Ethical considerations 
Approval to conduct the study will be obtained from the Human Research Ethics Committee (Medical) and the 
Postgraduate Committee of the University of the Witwatersrand. 
The study will be a survey using an anonymous self-administered questionnaire (Appendix 1). Those agreeing 
to participate in the study will be given an information letter (Appendix 2) outlining the purpose of the study and 
what will be required of them. Completion of the questionnaire will be voluntary and consent will be implied by 
returning the questionnaire.  
Questionnaires will contain no identifying data and will be returned into a sealed box marked “returned 
questionnaires”. Only the researcher and the supervisors will have access to the raw data. These measures will 
ensure anonymity and confidentiality.  
Data obtained will be stored securely for six years after completion of study. 
Should it be found that the anaesthetists are not confident to perform FOI and the FOI practice of the department 
is not optimal, the Head of Department will be notified with a view to instituting teaching programs. 
The study will be conducted according to the principles of the Declaration of Helsinki (22) and the South 
African Guidelines for Good Clinical Practice (23). 
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5.8 Data collection 
5.8.1 Research design 
A prospective, contextual, descriptive research design will be followed in this study. 
In a prospective study, an outcome is observed after following a certain population for a period of time (24). 
This study will be prospective as the data will be collected at the time the study takes place. The exposure to 
FOI, the practice of FOI as well as confidence of anaesthetists to perform FOI will be described. 
A contextual study refers to a particular population or group referred to as a “small-scale world” (25). Examples 
include a ward or a clinic in the hospital. This study will be conducted amongst anaesthetists working in the 
Department of Anaesthesiology at Wits and is therefore contextual.  
A descriptive study examines certain characteristics of a population as they naturally occur (26). This study will 
describe the current practice of awake FOI.  
5.8.2 Study population 
The study population consists of the anaesthetists working in the Department of Anaesthesiology.  
5.8.3 Study sample 
5.8.3.1 Sample method 
In this study a convenience sampling method will be used. Convenience sampling or availability sampling 
involves participants that are readily available to the researcher (24). All anaesthetists attending academic 
meetings will be approached to participate in the study. 
5.8.3.2 Sample size  
The Department of Anaesthesiology consist of 219 anaesthetists. Questionnaires will be administrated to the 
entire accessible population. A response rate of approximately 60% (131 participants) will be considered 
acceptable. 
5.8.3.3 Inclusion and exclusion criteria 
Inclusion criteria in this study are: 
 all anaesthetists attending the academic departmental meetings   
 anaesthetists agreeing to participate  
 complete and incomplete questionnaires.    
Exclusion criteria in this study are questionnaires returned blank. 
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5.8.4 Data collection 
5.8.4.1 Development of a questionnaire 
A questionnaire was chosen as an instrument for data collection because it: 
 determines what people know, think or believe 
 is an effective tool to direct questions to the population of concern 
 allows data collection from large groups (24). 
After reviewing the literature, a draft questionnaire (Appendix 1) was developed by the researcher ensuring 
content validity. Face validity was ensured by incorporating the suggestions of three anaesthesiologists with 
airway expertise reviewing the questionnaire.  It should take participants no longer than 15 minutes to complete 
the questionnaire. 
The self-administered questionnaire (Appendix 1) consists out of 3 sections.  
Section 1 includes the following demographic data: 
 age 
 gender 
 years of experience in anaesthesia 
 professional designation. 
Section 2 contains questions regarding exposure to and confidence in performing awake FOI including: 
 number of FOI’s performed 
 how participants were trained in FOI 
 level of confidence 
 aspects contributing to proficiency in this skill. 
Section 3 consists of questions regarding the process of performing FOI: 
 positioning the patient 
 pre-medication 
 sedation 
 topical anaesthesia 
 positioning of the anaesthetist. 
5.8.4.2 Data collection process 
The data will be collected at the departmental academic meetings. Questionnaires will be handed out to 
attendees who are willing to participate. An information letter (Appendix 2) regarding the study will be attached 
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to the questionnaire. The researcher will be present throughout to attend to queries. Participants will return 
questionnaires to a sealed box marked “returned questionnaires”. 
Blank questionnaires returned will be used to calculate the response rate but will not be included in the analysis 
of the data. Incomplete questionnaires will be included provided that more than 80% of the section on practice 
has been completed. 
5.8.5 Data analysis 
Data will be entered into a Microsoft Excel
®
 spreadsheet and analysed using descriptive and inferential 
statistics. The statistical program Statistica version 12.5 will be used. 
Categorical data will be analysed using frequencies and percentages and comparisons will be done using a Chi
2
 
or Fishers Exact test. 
5.9 Significance of the study 
Anaesthetists should regularly perform awake FOI to acquire and maintain both the skills and confidence to 
appropriately manage the anticipated difficult airway. If anaesthetists are not adequately exposed to the practice 
of awake FOI, teaching opportunities could be established to ensure anaesthetists become proficient in FOI.  
Performing awake FOI in a structured and standardised fashion may be especially beneficial for trainee 
anaesthetists. Auditing the practice of awake FOI in the Wits Department of Anaesthesiology may identify 
variability in the methods utilised during this procedure. A standard operating procedure for the process of 
awake FOI may be developed which may ultimately optimise patient care. 
5.10 Validity and reliability of the study 
Validity describes the extent to which a true value is being represented by a measurement. A study is valid if the 
conclusions are justified based on the study design (27). 
Reliability refers to the consistency with which a measure is achieved and to which random error occurs (27). 
In this study validity and reliability will be maintained by the following: 
 applying the appropriate research design 
 reviewing the literature for content validity of the questionnaire 
 incorporating suggestions of three anaesthesiology airway experts to ensure face validity of the 
questionnaire  
 completion of a standardised questionnaire by participants 
 preventing data contamination by the researcher being present during data collection 
 checking every 10th data entry point for accuracy. 
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5.11 Potential limitations of the study 
The contextual design of the study means that the results may not be generalizable to other anaesthesiology 
departments. It will however provide valuable information regarding the practice of FOI in the Wits Department 
of Anaesthesiology. 
A convenience sample may not adequately represent the practice of the entire Wits Department of 
Anaesthesiology but rather that of the participants present at the meeting. The results may therefore over- or 
under represent certain elements. 
The sample size will be determined by the willingness of the attendees to participate. A small sample size may 
limit the comparison between the professional designation and the level of confidence. 
5.12 Project outline 
Activity Nov 
2015 
Dec 
2015 
Jan 
2016 
Feb 
2016 
Mar 
2016 
June 
2016 
Jul 
2016 
Aug 
2016 
Sept 
2016 
Oct 
2016 
Proposal           
Proposal 
submission 
          
Ethics 
approval 
          
Postgrad 
Approval 
          
Data 
collection 
          
Data 
analysis 
          
Chapter 
4,5 
          
Submission           
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5.13 Financial plan 
The Department of Anaesthesiology will incur the cost of printing and paper for the proposal, ethics and 
postgraduate approvals and questionnaires. 
Item Number Cost Total 
Printing 1000 R1/page R1000 
Binding 4 R200 R800 
Total   R1800 
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Appendix 1: Questionnaire 
Please mark the appropriate box with X. In section 3, more than one answer may apply. 
Section 1 – Demographic information 
1.1 Gender 
Male  
Female  
 
1.2 Age 
25-30 years  
31-35 years  
36-40 years  
41-45 years  
46-50 years  
>50years  
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1.3 Professional designation 
Medical officer  
Registrar – 1st, 2nd, 3rd year  
Registrar – 4th year  
Career medical officer/Consultant  
 
1.4 Years of experience in anaesthesia 
≤5 years  
>5 years  
 
Section 2 – Exposure and training 
2.1 Approximately how many awake fibreoptic 
intubations have you performed? 
Nil  
1-5  
6-10  
11-20  
20-50  
>50  
 
If you have selected ‘Nil’ in 2.1 please do not proceed with the questionnaire.  
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2.2 On average how often do you usually perform awake 
fibreoptic intubation? 
Almost never  
Daily  
Weekly  
Monthly  
Annually  
Other  
 
If other, please specify. 
.………………………………………………………………………………………………….…………………
……………………………………………………………………………….. 
2.3 How were you trained to perform fibreoptic 
intubation? More than one option may apply. 
Nil  
Manikin   
Simulator  
Patient - asleep  
Patient - awake  
Other  
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If other, please specify. 
.……………………………………………………………………………………………………………………
………………………………………………………………………………. 
 
2.4 How would you rate your level of confidence in 
performing awake fibreoptic intubation? 
Very low  
Low  
Average  
High  
Very high  
 
2.5 How would you rate the contribution of the following 
aspects to your proficiency in this skill? 
Strongly 
agree 
Agree Disagree Strongly 
disagree 
Equipment availability     
Equipment functionality     
Number of cases available     
Practicing on normal airways     
Airway workshops      
Time available     
Availability of a FOI algorithm      
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Section 3 – Practice of awake fibreoptic intubation 
3.1 How do you usually position the patient? 
Prone  
Sitting  
Supine  
Other  
 
If other, please specify. 
………………………………………………………………………………………………………………………
………………………………………………………………………… 
 
3.2 (a) Do you administer premedication? Yes  
 No  
 
3.2 (b) If yes, please indicate the drug(s), dose and route 
of administration. 
Indicate 
with X 
Dose in a 
70kg patient 
Route of 
administration 
Atropine    
Glycopyrrolate    
Scopolamine    
Other    
 
If other, please specify drug, dose and route of administration. 
………………………………………………………………………………………………………………………
…………………………………………………………………………… 
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3.3 (a) Do you sedate the patient? Yes  
 No  
 
3.3 (b) If yes, which technique do you usually use? 
Titrate boluses  
Infusion  
Target Controlled Infusion  
Other  
 
If other, please specify. 
……………………………………………………………………………………………………………………… 
3.3 (c) Which drug(s) do you usually use for sedation? 
Midazolam  
Diazepam  
Fentanyl  
Remifentanil  
Propofol  
Ketamine  
Dexmedetomidine  
Other  
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If other, please specify. 
………………………………………………………………………………………………………………………
………………………………………………………………………........ 
 
3.4 (a) Do you apply topical anaesthesia to the airway 
prior to intubation? 
Yes  
 No  
 
3.4 (b) If yes, which technique(s) do you use? 
Apply soaked swabs  
Apply gel or ointment  
Nebulise  
Spray  
Spray-as-you-go  
Other  
If other, please specify. 
………………………………………………………………………………………………………………………
…………………………………………………………………………… 
  
71 
 
3.4 (c) Which drug(s) do you use for topicalisation? 
Benzocaine  
Bupivicaine 0.5%  
Cocaine  
Lignocaine 2%  
Lignocaine 10%  
Tetracaine  
Other  
 
If other, please specify. 
………………………………………………………………………………………………………………………
…………………………………………………………………………… 
 
3.5 How do you usually position yourself to intubate? 
Facing the patient  
Behind the patient  
Elevated  
Same level as the patient  
Other  
 
If other, please specify. 
………………………………………………………………………………………………………………………
…………………………………………………………………………… 
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3.6 Which approach do you usually use? 
Oral  
Nasal  
Retrograde  
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Appendix 2: Information sheet 
Dear Colleague 
My name is Dr Elize van Rooy. I am a registrar in the Wits Department of Anaesthesiology. I would like to 
invite you to participate in a research project titled “Anaesthetists’ practice of awake fibreoptic intubation in 
adult patients“. The study report will be submitted to the Faculty of Health Sciences at the University of the 
Witwatersrand to for partial fulfilment of the requirements for my MMed degree. 
The aim of the study is to describe the exposure, level of confidence and practice of awake fibreoptic intubation 
in adult patients by anaesthetists working in the Wits Department of Anaesthesiology. As airway specialists it is 
important that the anaesthetist can skilfully manage the anticipated difficult airway in a confident manner. This 
will be determined by a self-administered questionnaire. 
Participation is completely voluntary and consent will be implied by your completion and return of a 
questionnaire. Information will be kept confidential and anonymous as none of your personal details will be 
required and only the researcher and supervisors will have access to the raw data. There is no penalty for not 
participating in the study. 
Kindly return all questionnaires, whether completed or not, to the box marked “returned questionnaires”. The 
numbering of questionnaires is simply for determining the response rate and for data capturing purposes. 
Completing the questionnaire should take no longer than 15 minutes. Participants are encouraged not to share 
information as this can produce inaccurate results. No incentives will be provided for completing the 
questionnaire.  
Please ensure that you understand the above information prior to completing the survey. 
Thank you for taking the time to read this information section. If you have any questions please do not hesitate 
to contact us: 
Elize van Rooy (researcher): 082 569 7947 
The Chairman of the HREC: (011) 717 1234 
Yours sincerely, 
Elize van Rooy 
 
 
